Literature DB >> 27702560

"To Be or Not to Be": Immune Tolerance in Chronic Hepatitis B.

Ulrike Protzer1, Percy Knolle2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27702560     DOI: 10.1053/j.gastro.2016.09.038

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

Review 1.  Tolerance and immunity to pathogens in early life: insights from HBV infection.

Authors:  Michelle Hong; Antonio Bertoletti
Journal:  Semin Immunopathol       Date:  2017-07-06       Impact factor: 9.623

2.  A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B.

Authors:  Allan Ma; Bruce Motyka; Klaus Gutfreund; Yuenian Eric Shi; Rajan George
Journal:  Hum Vaccin Immunother       Date:  2019-12-12       Impact factor: 3.452

3.  Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant.

Authors:  Pil Soo Sung; Dong Jun Park; Jung-Hee Kim; Ji Won Han; Eun Byul Lee; Gil Won Lee; Hee Chul Nam; Jeong Won Jang; Si Hyun Bae; Jong Young Choi; Eui-Cheol Shin; Su-Hyung Park; Seung Kew Yoon
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

4.  Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

Authors:  D C Whitacre; C J Peters; C Sureau; K Nio; F Li; L Su; J E Jones; M Isogawa; M Sallberg; L Frelin; D L Peterson; D R Milich
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

5.  Platelet-to-Portal Vein Width Ratio and Platelet-to-Spleen Thickness Ratio Can Be Used to Predict Progressive Liver Fibrosis Among Patients With HBV Infection With HBeAg-Negativity and a Normal ALT Level.

Authors:  Mudan Feng; Lan Lei; Jian Xu; Yuzhi Shi; Wenfeng Yang
Journal:  Front Med (Lausanne)       Date:  2022-06-21

6.  Evaluation of antiviral - passive - active immunization ("sandwich") therapeutic strategy for functional cure of chronic hepatitis B in mice.

Authors:  Bisheng Shi; Yanling Wu; Chunyu Wang; Xiaofang Li; Fan Yu; Bin Wang; Zhenlin Yang; Jianhua Li; Mifang Liang; Yumei Wen; Tianlei Ying; Zhenghong Yuan
Journal:  EBioMedicine       Date:  2019-11-01       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.